article thumbnail

Wasted: $1 of Every $4 Spent on Health Care In America

Health Populi

Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. The Centers for Medicare and Medicaid Services (CMS) forecasts that prescription drug spending will be the fastest-growing cause of rising health spending by 2027.

article thumbnail

Global Digital Dose Inhalers Market Report to 2027: North America is Expected to Dominate the Market

Digital Health Global

DUBLIN–(BUSINESS WIRE)–The “Digital Dose Inhalers Market Insights, Competitive Landscape, and Market Forecast – 2027” report has been added to ResearchAndMarkets.com’s offering. The global digital dose inhalers market will grow at a CAGR of 11.27% during the forecast period from 2022 to 2027.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

It’s a volume speaking volumes on the current picture of prescribed meds, spending and revenues, health care utilization trends, and a forecast looking out to 2027. Reviewing the annual 2023 report from the IQVIA Institute for Human Data Science discussing The Use of Medicines in the U.S. health care: “Wake up, public health!”

article thumbnail

Consumers and Cancer: 3 Patient-Focused Charts From IQVIA on the State of the Oncology in 2023

Health Populi

Just in time for #ASCO2023, the IQVIA Institute published their annual report on Global Oncology Trends 2023 – Outlook to 2027 , an update featuring pipelines, therapy approvals, research updates, costs of oncology products, and patients. in 2023, and millions of more people worldwide.

article thumbnail

Medical costs projected to increase 6% by 2020, says PwC

Henry Kotula

Between 2020 and 2027, retail drug spending under private health insurance is projected to increase at a rate of 3 percent to 6 percent a year as the impact of generics on spending plateaus, biosimilars continue to see slow uptake, and costly new therapies enter the market. WHAT’S THE IMPACT. One is that drug spending will grow faster.

article thumbnail

National Health Spending Will Reach Nearly 20% of U.S. GDP By 2027

Health Populi

every year from 2020 to 2027, the actuaries at the Centers for Medicare and Medicaid Services forecast in their report, National Health Expenditure Projections, 2018-2927: Economic And Demographic Trends Drive Spending And Enrollment Growth , published yesterday by Health Affairs. GDP By 2027 appeared first on HealthPopuli.com.

Medicare 227